Carvedilol protected diabetic rat hearts via reducing oxidative stress.
- Author:
He HUANG
1
;
Jiang SHAN
;
Xiao-hong PAN
;
Hui-ping WANG
;
Ling-bo QIAN
Author Information
1. Department of Cardiology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China. huanghell@163.com
- Publication Type:Journal Article
- MeSH:
Animals;
Antioxidants;
pharmacology;
Blood Glucose;
analysis;
Body Weight;
drug effects;
Carbazoles;
pharmacology;
Diabetes Mellitus, Experimental;
drug therapy;
metabolism;
Heart;
drug effects;
Male;
Malondialdehyde;
analysis;
Myocytes, Cardiac;
metabolism;
Oxidative Stress;
drug effects;
Propanolamines;
pharmacology;
Proto-Oncogene Proteins c-bcl-2;
genetics;
RNA, Messenger;
analysis;
Rats;
Rats, Sprague-Dawley;
Reverse Transcriptase Polymerase Chain Reaction;
Streptozocin;
Systole;
drug effects
- From:
Journal of Zhejiang University. Science. B
2006;7(9):725-731
- CountryChina
- Language:English
-
Abstract:
Oxidative stress plays a dominant role in the pathogenesis of diabetes mellitus. Bcl-2 gene has close connection with antioxidant stress destruction in many diseases including diabetes. Carvedilol, an adrenoceptor blocker, also has antioxidant properties. To study the effect of carvedilol on the antioxidant status in diabetic hearts, we investigated carvedilol-administrated healthy and streptozotocin-induced diabetic rats. After small and large dosage carvedilol-administered for 5 weeks, hemodynamic parameters, the levels of malondialdehyde, activities of antioxidant enzymes and expression of Bcl-2 mRNA in the cardiac tissues were measured. The diabetic rats not only had cardiac disfunction, weaker activities of antioxidant enzymes, but also showed lower expression of Bcl-2. Carvedilol treatment increased activities of antioxidant enzymes and expression of Bcl-2 in healthy rats as well as diabetic rats. These results indicated that carvedilol partly improves cardiac function via its antioxidant properties in diabetic rats.
